The regular use of aspirin was associated with a reduced risk of two deadly cancers — ovarian and hepatocellular carcinoma, which starts in the liver.

Two studies published Thursday in JAMA Oncology, conducted using information from the Nurses’ Health Studies, suggest the risk for each type of cancer decreases between 20 and 50 percent with aspirin use.

One study looked at the risk for hepatocellular carcinoma, the most common type of primary liver cancer in adults and common cause of death in people with cirrhosis. The other focused on ovarian cancer, a highly fatal malignant neoplasm with few modifiable risk factors.

Read more


Related Articles


Comments